INAB·45674E208·US·equity·Healthcare - Biotechnology-Activist
INAB (IN8BIO INC) is held by 11 institutional investors as of Q1 2026. Largest holders: Alyeska Investment Group, L.P. ($1.4M), FRANKLIN RESOURCES INC ($1.4M), GEODE CAPITAL MANAGEMENT, LLC ($127,635). Net institutional sentiment: Bearish.
See how INAB's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer